Participate in Research

Here is a list of surveys and studies beyond clinical drug trials looking for input from people living with Essential Thrombocythemia, Myelofibrosis and Polycythemia Vera. We list these as a service to patients who may want to be involved in informing the research process. This is not an endorsement of any of the surveys or companies listed below.

Myelofibrosis Patients Journey - This project, sponsored by Celgene Corporation, is available to Myelofibrosis patients who live in the European Union.  The purpose of the research is to quantify the emotional and attitudinal MF patient journey across different points in time, focusing specifically on the emotions experienced, any practical impact of the condition and its symptoms, your attitudes towards HCPs and treatments and any information sources you have utilized.

The research will take the form of a 45-minute in-depth telephone interview with web assistance and should you qualify to take part you will be compensated for your time with an honorarium of £50. The research will be conducted in accordance with the MRS Guidelines, BHBIA Legal & Ethical Guidelines, the ABPI Code of Practice and Data Protection Legislation. Click here to learn more about the study and to participate.

Gilead is sponsoring a research project - Is currently seeking participants for a study about experience with MPN symptoms. Do you experience symptoms of MPN? Are you 18 years old or older? Are you willing to be interviewed in person about your experience with MPN? If so, you may be eligible to participate in this study. Participants will receive compensation for their time. The study meeting will take approximately 2 hours of your time. For more information about this study, please call 1-800-762-8138 and leave your contact details for Hafiz Oko-osi.

REVEAL study for Polycythemia Vera:  An observational study of patients receiving usual care for Polycythemia Vera, sponsored by Incyte Corporation. Incyte is partnering with approximately 200 community and academic medical centers to conduct the study in the U.S. REVEAL, which recently began enrolling patients, is expected to include 2,000 patients under the supervision of a physician for the active management of PV for a period of three years. Click here to learn more or participate.

An ET research study by QuintilesIMS  (sponsored by Incyte Corporation) to learn which symptoms of ET are the most common, and how these symptoms typically affect the lives of patients who live with the disease. This understanding may help improve how the patient’s experience is accounted for in clinical trials that measure the effect of disease treatments. Please click here for a description of the study and inclusion and exclusion criteria for ET research study.

If you have myelofibrosis (MF), Pfizer wants to hear from you as they build an understanding of the experience of people living with the disease. Pfizer (who has a Phase 2 clinical trial in MF right now) is working with Adelphi Values to conduct paid interviews with patients with MF. The primary goal of these interviews is to obtain feedback on a questionnaire used to assess symptoms of MF. If you want more information please email

Click here to view completed surveys and studies and to learn about the results.

Take the steps you need to help change your prognosis.



Get free, timely information on living with an MPN.